Calcium acetate Pregnancy and Breastfeeding Warnings

Brand names: Calphron, Eliphos, PhosLo, PhosLo Gelcap, Phoslyra

Medically reviewed by Drugs.com. Last updated on Dec 21, 2023.

Calcium acetate Pregnancy Warnings

This drug should be used only if clearly needed.

US FDA pregnancy category: C

Comments:
-Treatment may lead to hypercalcemia.
-Hypercalcemia risk increases with concomitant calcium and vitamin D use.
-Maintaining normal serum calcium is important for maternal and fetal well-being.
-Maternal hypercalcemia increases the risk for stillbirth, preterm birth, and neonatal hypocalcemia and hypoparathyroidism.
-Maternal calcium acetate use is not expected to harm a fetus, provided maternal serum calcium levels are appropriately monitored.

Animal studies have not been conducted. There are no controlled data in human pregnancy.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

See references

Calcium acetate Breastfeeding Warnings

This drug should be used only if clearly needed.

Excreted into human milk: Yes

Comments:
-Maternal calcium acetate use is not expected to harm an infant, provided maternal serum calcium levels are appropriately monitored.

See references

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer